Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1310405-37-8 | MDL No. : | MFCD12028657 |
Formula : | C9H11BN2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FOUSXGGKIFZVIQ-UHFFFAOYSA-N |
M.W : | 190.01 | Pubchem ID : | 44119494 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 55.79 |
TPSA : | 58.28 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.83 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.88 |
Log Po/w (WLOGP) : | -0.44 |
Log Po/w (MLOGP) : | 0.04 |
Log Po/w (SILICOS-IT) : | -0.74 |
Consensus Log Po/w : | -0.05 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.98 |
Solubility : | 1.98 mg/ml ; 0.0104 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.69 |
Solubility : | 3.9 mg/ml ; 0.0205 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.75 |
Solubility : | 3.36 mg/ml ; 0.0177 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.93 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetrakis(triphenylphosphine) palladium(0); potassium carbonate; In 1,4-dioxane; water; at 100.0℃; for 1.0h;Inert atmosphere; Sealed tube; | Example 75 Method AZ: Preparation of (S)-2-tert-butoxy-2-(7-(4-chlorophenyl)-2-(1,3-dimethyl-1H-indazol-6-yl)-5-methylbenzo[d]thiazol-6-yl)acetic acid (209) Preparation of (S)-ethyl 2-tert-butoxy-2-(7-(4-chlorophenyl)-2-(1,3-dimethyl-1H-indazol-6-yl)-5-methylbenzo[d]thiazol-6-yl)acetate: To a vial flushed with argon was added (S)-ethyl 2-(2-bromo-7-(4-chlorophenyl)-5-methylbenzo[d]thiazol-6-yl)-2-tert-butoxyacetate (100 mg, 0.202 mmol), <strong>[1310405-37-8]1,3-dimethyl-1H-indazol-6-ylboronic acid</strong> (76 mg, 0.4 mmol), Pd(PPh3)4 (23 mg, 20 mumol), and K2CO3 (83 mg, 0.6 mmol). De-gassed dioxane (1.6 mL) and water (0.4 mL) were then added, and the reaction was heated to 100 C. for 1 h. After cooling to 23 C., the reaction was filtered over a plug of Celite, concentrated, and purified by column chromatography (gradient 0 to 30% EtOAc in hexanes) to give the product. LCMS-ESI+: calc'd for C31H33ClN3O3S: 562.2 (M+H+). Found: 562.3 (M+H+). Preparation of (S)-2-tert-butoxy-2-(7-(4-chlorophenyl)-2-(1,3-dimethyl-1H-indazol-6-yl)-5-methylbenzo[d]thiazol-6-yl)acetic acid: |
[ 1260366-15-1 ]
(1,3-Dimethyl-1H-indazol-4-yl)boronic acid
Similarity: 0.97
[ 1309982-19-1 ]
(1,3-Dimethyl-1H-indazol-7-yl)boronic acid
Similarity: 0.92
[ 1253912-00-3 ]
(2,3-Dimethyl-2H-indazol-6-yl)boronic acid
Similarity: 0.92
[ 2304635-52-5 ]
(2,3-Dimethyl-2H-indazol-5-yl)boronic acid
Similarity: 0.92
[ 2304634-35-1 ]
(2,3-Dimethyl-2H-indazol-4-yl)boronic acid
Similarity: 0.89
[ 1260366-15-1 ]
(1,3-Dimethyl-1H-indazol-4-yl)boronic acid
Similarity: 0.97
[ 1309982-19-1 ]
(1,3-Dimethyl-1H-indazol-7-yl)boronic acid
Similarity: 0.92
[ 1253912-00-3 ]
(2,3-Dimethyl-2H-indazol-6-yl)boronic acid
Similarity: 0.92
[ 2304635-52-5 ]
(2,3-Dimethyl-2H-indazol-5-yl)boronic acid
Similarity: 0.92
[ 2304634-35-1 ]
(2,3-Dimethyl-2H-indazol-4-yl)boronic acid
Similarity: 0.89